Virbac Stock Rises Nearly 2% and Crosses a Technical Threshold
The veterinary laboratory in Carros recovers mid-morning in a well-oriented Parisian market. The stock regains ground above a short-term technical reference after several sessions of consolidation around its moving averages.
A Rebound Bringing the Price Above the 20-Day Moving Average in a Supportive Market
Virbac stock gains 1.57% to €356.50, up from €351 the previous day. Meanwhile, the SBF 120 index is up by 0.33% and the CAC 40 by 0.32%. The stock ranks high in the broad index but does not feature among the session's most significant gains.
The rebound brings the price just above the 20-day moving average, at €353.73, a mark it fell below at the end of May. The 50-day moving average at €359.76 remains slightly above the current price and represents the next short-term hurdle, while the 200-day moving average (€348.79) provides substantial support, with the stock trading 2.2% above it. The RSI at 46 indicates a neutral setup, consistent with a breathing movement after a monthly decline of 1.66%.
Annual Dynamics Preserved Despite Recent Weeks' Consolidation
Year-on-year, Virbac maintains a gain of 8.19%, and the three-month performance remains positive at 2%. The recent sequence is more turbulent: -0.97% over the week and -1.66% over thirty days, following the peak of €369 on May 21, when TP Icap had raised its target to €412. Since then, the stock has retreated about 3% and has been trading between its support at €339 and resistance at €378.50.
The one-month volatility remains contained at 7.33, which aligns with the absence of any specific catalyst for the group this Friday. The next technical marker to watch is the 50-day moving average, crossing which could open the way to the €369-378.50 zone tested in mid-May.
